Latest Industry Insights

Technology Networks spoke with Arvind Kothandaraman to find out about the technologies underpinning syndromic testing, recent advances in the field and its possible role in pandemic prevention.

In this interview, Sebastian Selzer discusses the advantages of cell culture in stirred-tank bioreactors.

In this interview, we learn more about the support available for entrepreneurs looking to take their ideas from the bench to viable business.

In this opinion piece, Daniel Elgort takes a look at how bioinformatics has already shaped the cancer care landscape and how its role will continue to grow over time.

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.

In this article, we explore how equipment, laboratory and experimental approaches can accelerate failure so companies change and adjust their approach before it’s too late.

To learn more about cell and gene therapy and some of the challenges facing the industry and the benefits that automation can bring, Technology Networks spoke with Nirupama Pike PhD, senior director of technical affairs at Thermo Fisher Scientific.

This article walks through the fundamentals of CRISPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.

This article discusses how specialized charge detection mass spectrometers have been developed to enable simultaneous charge detection and decipher large and complex macromolecules, ultimately increasing accuracy and providing high-resolution measurements for better analysis of biotherapeutics.

In this interview with Anthony Schmitt PhD, senior vice president of science at Arima Genomics, we discover some of the advantages and applications of 3D genomics for fields such as cancer research and drug discovery.